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Recessive dystrophic epidermolysis bullosa  (RDEB) ~ is  a  debilitating and often 
fatal disease characterized by repeated blistering after minor trauma. The morpho- 
logic finding of collagen degeneration (1) coupled with increased collagenase activity 
in  explant  cultures  of skin  from  RDEB  patients  (2,  3)  suggested  that  excessive 
collagenase might be repsonsible for the blistering phenomenon. This postulate was 
further substantiated by the demonstration of increased tissue levels of immunoreac- 
tive eollagenase (iHSC) in both the unaffected and blistered skin of RDEB patients 
(4).  Evidence that  some abnormality in  the  regulation of collagenase synthesis or 
activity was important in the pathogenesis of the disease was obtained when collagen- 
ases derived from skin fibroblast cultures of two patients with RDEB were shown to 
be structurally altered (5). The enzymes, which appeared to be overproduced in cell 
culture,  demonstrated  increased  thermolability  and  reduced  affinity for  Ca  2+,  a 
cofactor required both for enzyme activity and thermal stability (6). In addition, there 
was decreased activity per unit immunoreactive protein, raising the question of the 
relationship of the altered enzymes to the blistering phenomenon. 
If a primary defect in the regulation of synthesis and/or degradation of collagenase 
were basic to the etiology of RDEB, k  might be expected that  increased levels  of 
iHSC would be seen in fibroblast cultures. Thus, it seemed essential to determine (a) 
whether a  quantitative increase in iHSC and/or collagenase activity could be found 
in  RDEB  fibroblast cultures,  (b)  whether such a  phenotypie trait persists through 
many cell passages, (c) whether this trait might be utilized to distinguish RDEB from 
other  genetic  forms  of the  disease,  and  (d)  the  extent  to  which  heterogeneity is 
manifested within the fibroblast cultures of various RDEB patients. 
Materials and Methods 
Cell Cultures.  RDEB  fibroblast euhures were established from a  3-ram skin punch biopsy 
after obtaining informed consent. Control cultures were initiated from healthy volunteers or 
were purchased from The American Type Cell Culture Collection, Roekville, Md. As a further 
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TABLE  I 
Description of Human Skin Fibroblast Lines 
Controls  RDEB  REBL  DDEB  DEBS 
WUN 76128  (F 47)*  WUE 7506 (F 12)$  WUE 7515 (F 30)  WUE 76111  (M 20) 
CRL 1141 (M 3)  WUE 7565 (F 3)§  WUE 7510 (M 15)11  WUE 7560 (F 12) 
CRL 1187 (M 14)  WUE 76108  (M 4)  WUE 7514 (M 14)1[  WUE 7512 (M 19) 
CRL 1119 (M 15)  WUE 7504  (F 8)  WUE 7513 (M 1) 
CRL 1124 (F 40)  WUE 7564 (F 1)  WUE 7570 (F 25) 
WUN 76130  (F 20)  WUE 77200  (F 4)  WUE 7557 (M 21) 
WUN 76131  (F 27)  WUE 76114  (M 1)  WUE 7503 (F 2) 
CRL 1121 (M 3)  WUE 76124  (F 1 too)  WUE 7508 (F 10) 
CRL 1106 (fetus)¶  WUE 7505 (F 14)  WUE 7562 (F 64) 
WUE 7572 (F 34) 
WUE 76103 (F 32) 
WUE 76102  (F 14) 
WUE 7567 (M 4) 
WUE 7535 (M 10) 
WUE 7502 (F 19) 
* Donor, sex, and age are noted in parenthesis. 
$ WUE 7506 previously reported as RDEB-FC (5). 
§ WUE 7565 previously reported as RDEB-TH (5). 
II WUE 7510 and WUE 7514 described previously as cases  1 and 2 (7) and as cases 4 and 5 (8), respectively. 
¶ Sex unknown (See ATCC Catalog, 1975). 
control, fibroblast cultures were established from patients with other genetically distinct forms 
of epidermolysis bullosa (EB)--recessive EB  letalis, dominant dystrophic EB, and dominant 
EB simplex. All patients were examined by one of us (E.A.B.) and classified based on clinical, 
genetic, and histologic findings as described previously (4). The cell lines employed in this study 
are detailed in Table I. 
Cells were  grown  in  plastic culture flasks  (Coming Glass Works, Science Products  Div., 
Coming, N.Y.) in Dulbecco's modified Eagle's medium-high glucose +  glutamine (Microbio- 
logical Associates, Walkersville, Md.) with 0.03 M  N-2-hydroxyethylpiperazine-N'-2-ethanesul- 
fonic acid (Hepes) buffer (pH 7.6), 20% fetal calf serum, and 200 U of penicillin and 200 #g of 
streptomycin per ml at  37°C.  In most of the experiments to determine the concentration of 
iHSC in the culture medium, fibroblasts were grown to early confluence, a cell density at which 
collagenase accumulation is greatest (9). Serum-containing medium was then removed, the cells 
were washed four times with Hanks' balanced salt solution, and the cultures were maintained 
in serum-free Dulbecco's modified Eagle's medium-HG +  glutamine for 24 h. This serum-free 
medium was then dialyzed against 4,000 vol of distilled water, lyophilized, and stored at -80°C 
until assayed. 
In studies to assess the specific activity of collagenase in RDEB fibroblast cultures, cells were 
grown in plastic roller bottles (490 cm  2, Coming Glass Works) or in 75 cm  2 plastic culture flasks 
(BioQuest, BBL & Falcon Products, Becton, Dickinson, & Co., Cockeysville, Md.). At conflu- 
ence, the cells were maintained for 24-48 h in serum-free medium, after which the medium was 
concentrated and assayed for collagenase activity and immunoreactive enzyme protein. 
Enzyme Assays. Human  skin  procollagenase was  activated proteolytically with  trypsin as 
described previously (10).  For each  enzyme  preparation, a  range of trypsin concentrations 
(0.1-2.0 #g trypsin per 50 #1 enzyme sample) was employed to ensure that maximal collagenase 
activity was measured. After preincubation with trypsin for 10 min at 25°C, at least a fivefold 
molar excess of soybean trypsin inhibitor was added to inhibit further trypsin activity. Each 
mixture was then assayed for collagenase activity at 37°C in 0.05 M  Tris-HCl (pH 7.5) in the 
presence  of  10  mM  CaCI2  using  native,  reconstituted  [14C]glycine-labeled collagen  fibrils 
containing approximately 3,000 cpm per substrate gel (11). 
The levels of collagenase in certain RDEB fibroblast cultures were compared with those of 
fl-glucuronidase, a  lysosomal enzyme, and lactate dehydrogenase, a  cytoplasmic enzyme. In 
these studies, after harvesting the serum-free culture medium, the cells were washed with Hanks' 
balanced salt solution, lysed with a Sonic Dismembrator for 30 s at an intensity of 60 dB and 
assayed for protein, fl-glucuronidase (12),  and lactate dehydrogenase (13) using kits obtained 
commercially (Sigma Chemical Co., St. Louis, Mo.). 
Collagenase Radioimmunoassay. iHSC  was  measured  by a  slight modification of the  double 
antibody radioimmunoassay previously reported (14). The procollagenase used as the unlabeled 
standard and for iodination in the radioimmunoassay was purified to homogeneity from cell 
culture medium as described by Stricklin et al. (15). This same enzyme preparation was used 1380  RECESSIVE DYSTROPHIC EPIDERMOLYSIS  BULLOSA 
to produce monospecific antiserum  to the  enzyme  (16). Standard radioimmunoassay  curves 
were performed  in duplcate with  disposable plastic  microfuge tubes  (Beckman Instruments, 
Inc.,  Fullerton,  Calif.) that  contained a  1:2,500 dilution  of the  gamma globulin  fraction  of 
antiserum  to  human  skin collagenase,  12SI-labeled human  skin eollagenase  (approximately 
20,000 cpm/tube) and 0-100 ng of electrophoretically  homogeneous human skin collagenase in 
a total vol of 250 #1. After incubation for 24 h at 4°C, goat anti-rabbit  IgG was added in excess. 
The  resulting  precipitates  were  isolated,  washed,  and  counted in  a  single channel  gamma 
scintillation  spectrometer.  Unknowns, consisting of the various collagenase preparations,  were 
reconstituted  in a small vol of 0.05 M Tris-0.15 M Na(21 buffer and assayed for immunoreactive 
enzyme protein  in an identical  fashion using 100-#1 portions of serial doubling dilutions of the 
enzymes. Controls  in which  nonimmune rabbit  gamma globulin  was substituted  for specific 
antiserum  were routinely  included. 
Protein Synthesis Studies.  General protein synthesis was measured in control and representative 
RDEB fibroblast  cultures.  In these studies, the cells were grown to confluence, washed, and 
placed in serum-free medium containing l0 #(2i/ml of a [x4(2]labeled amino acid mixture. After 
24 h at 37°(2, the cultures  were harvested  and total  protein  synthesis was determined  as the 
amount  of  [14(2]labeled amino  acids  incorporated  into  10%  trichloroacetic  acid-insoluble 
material  in the medium and cells. 
Other Assays.  Mean population doubling times of each cell line were determined  by seeding 
cultures  from a single large pool at low density. Replicate  cultures were fed serum-containing 
medium every 2 days for the length of the experiment.  Duplicate cultures were harvested daily 
for cell counts. Protein  (17) and DNA (18) were determined  using established  methods. 
Results 
In initial studies iHSC levels were determined in the fibroblast culture media of 10 
patients with RDEB, 3 with recessive EB letalis, 9 with dominant dystrophic EB, and 
5 with dominant EB simplex. As shown in Fig.  1, the mean concentration of iHSC in 
the cultures of the  10 RDEB patients was 328%  of the control cultures (P <  0.001). 
The range of values for iHSC content of the RDEB culture medium was  104-645% 
of control,  suggesting  considerable  heterogeneity  among  the  RDEB  patients.  In 
contrast, iHSC was found to be 95% of control in recessive EB letalis (range, 70-115%), 
91%  of control in dominant dystrophic EB (range, 39-138%), and 96% of control in 
dominant EB simplex (range, 79-130%). In no case were the levels of enzyme protein 
significantly different from those of control cultures (Fig.  1). 
Although the RDEB cultures as a  group had significantly increased iHSC concen- 
trations, the wide range of values found for the iHSC levels  suggested that heteroge- 
neity  in  the  quantity  of iHSC  being  produced  was  present.  This  possibility  was 
explored by comparing the iHSC production by each RDEB fibroblast line with that 
of control lines within a series of experiments rigidly controlled for growth conditions. 
In  these  experiments  the  cells  were  placed  in  serum-free  medium  only at  80-90% 
confluence. Furthermore, to minimize any variability in collagenase expression which 
might  be  caused  by pH  differences,  2 a  single  preparation  of culture  medium  was 
utilized for all  7 experiments. As a  group the RDEB cell lines displayed an approxi- 
mate  threefold  increase  in  iHSC/mg protein  (P <  0.01)  (Table  II).  Individually, 
however,  there  was  significant  variability  in  iHSC  production  with  8  of the  10 
fibroblast  lines  having significant  increases  in  iHSC  (Table  II).  Several  lines  had 
iHSC levels which were up to fivefold increased, but two lines,  WUE 7504 and WUE 
76124, failed to demonstrate any increase in iHSC concentration. 
2  D. B. Busiek and E. A. Bauer. 1978. Environmental pH modulation of collagenase in normal human 
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FIG.  1.  Immunoreactive  collagenase  concentration  of EB  fibroblast  cultures.  Collagenase was 
quantitated  as  ng iHSC/mg protein  in  the culture  medium of each EB group  in a  total of 21 
different  experiments.  RDEB  represents  10  different  cell  lines;  recessive  EB  letalis  (REBL),  3 
different cell lines; dominant dystrophic EB (DDEB), 9 different cell lines; dominant EB simplex 
(DEBS),  5 different cell lines. The values are presented as percent of control, so that comparisons 
can be made between experiments. Statistical analysis was made using an analysis of variance after 
it was determined that variances within groups were homogeneous by Bartlett's test. 
TABLE  II 
Production of lmmunoreactive Collagenase by Normal and RDEB Fibroblast 
Cultures 
Culture  Number*  Immunoreactive collagen-  p 
a~e 
nglmg protan~ 
Controls  22  1,274.0 +  199.2  -- 
RDEB 
WUE 7506  5  2,376.9  ±  263.6  <0.01 
WUE 7565  2  2,645.1  ±  100.8  <0.025 
WUE 76108  12  1,978.5 ±  305.5  <0.05 
WUE 7504  4  1,380.6 ±  210.6  NS§ 
WUE 7564  4  5,768.5  ±  1,414.1  <0.0125 
WUE 77200  4  2,831.0  ±  799.1  <0.005 
WUE 76114  5  6,439.9  :t:  1,615.5  <0.001 
WUE 76124  3  1,230.1  ±  327.7  NS§ 
WUE 7505  4  2,293.5  ±  778.0  <0.05 
WUE 7572  2  6,268.2  ±  468.0  <0.001 
* Number of cultures examined in each cell line. Controls represent  22 cultures 
examined in seven different experiments. 
Expressed as mean +  SE; the statistical  signifcance of each value is expressed 
relative to the control cultures using Student's t test. 
§ NS, not significant. 
Previous  studies  of the  collagenases  from  two  RDEB  cell lines  showed  decreased 
activity per unit  immunoreactive  protein  (5).  Thus,  this parameter  was  also  investi- 
gated  in  eight  of the  RDEB  cell  lines  (Table  III).  Collagenase  activity  displayed 
significant variation  between  fibroblast  lines, perhaps  due to variable loss of enzyme 
activity in structurally  comprised enzymes during the 24-h serum-free incubation,  as 
suggested  previously  (5).  It is noteworthy,  however, that  in five of the eight cell lines 1382  RECESSIVE DYSTROPHIC  EPIDERMOLYSIS BULLOSA 
TABLE  III 
Specific Activity of Collagenase  from RDEB Fibroblast Cultures 
Culture  Collagenase activ-  Immunoreactive  A/I§ 
ity*  collagenase:~ 
%C  %C  %C 
WUE 7506  138.5 ::t: 46.4  234.0 ±  42.9  59.2 
WUE 7565  20.6 ±  11.7  188.3 ±  17.4  10.9 
WUE 76108  112.8 ±  56.6  340.3 ±  92.1  33.1 
WUE 7504  66.4 ±  5.9  127.5 ±  41.3  52.1 
WUE 7564  102.4 ±  35.6  644.8  ±  121.8  15.9 
WUE 76114  138.6 ±  6.8  424.1  ±  75.8  32.7 
WUE 7505  20.0  242.9 ±  37.1  8.2 
WUE 7572  146.4 ±  29.7  668.6 ±  280.9  21.9 
* Collagenase activity determined as cpm,  [14C]collagen solubilized per mg 
protein in 5 h  at  37°C and expressed  as mean  ±  SE % of control for all 
experiments performed with each line. 
:~ Immunoreactive collagenase was quantitated as ng per mg protein as detailed 
in Fig.  1 and expressed as mean ±  SE % of control. 
§ Ratio of activity per immunoreactive protein. 
TABLE IV 
Comparison of CoUagenase Activity with Lysosomal and Cytoplasmic Enzymes in Normal and RDEB 
Fibroblast Cultures 
Culture  Collagenase  fl-Glucuronidase  Lactate dehydro- 
genase 









768.3 ±  393.3  119.2 ±  68.9  2.12  406.7 
4,047.6  580.4  2.36  508.2 
(526.8%C)  (487.1%C)  (111.3%C)  (125.0%C) 
2,217.5  360.0  3.75  334.1 
(288.6%C)  (302.1%C)  (176.9%C)  (82.1%C) 
704.1:1:134.9  157.5 ±  72.3  1.06  244.5 
2,947.0  593.3  1.00  269.9 
(418.6%C)  (376.7 %C)  (94.3%C)  ( 110.4 %C) 
1,370.7  252.0  1.34  222.8 
(194.7%C)  (160.0%C)  (126.4%C)  (91.1%C) 
* Controls represent  mean ±  SE values from two different  cell lines. 
examined  mean  collagenase  activity,  determined  as  activity  per  mg  protein,  was 
normal  or  increased.  Thus,  in  most  instances  it  appeared  that  the  disproportionate 
increase  in  immunoreactive  enzyme protein  was  largely responsible  for the decrease 
in  collagenase  activity per  unit  immunoreactive  protein.  Normal  human  skin  fibro- 
blast lines displayed little variability in either collagenase activity or immunoreactive 
protein.  The  mean  activity  was  75.6  +  20.5  cpm/#g  protein  (mean  +  SE)  while 
immunoreactive  enzyme was  1,003.7  -+  309.6  ng/mg  protein.  The  mean  variability 
for control cultures  between experiments was  27.4%. 
In two representative  RDEB  lines a  comparison  was made  between the enzymatic 
activity of collagenase and  that  of fl-glucuronidase,  a  lysosomal enzyme, and  lactate 
dehydrogenase,  a  cytoplasmic  enzyme.  As  depicted  in  Table  IV,  one  RDEB  line, 
WUE  7572,  showed  a  four-  to  fivefold  increase  in  collagenase  activity  in  these EUGENE  A.  BAUER  AND  ARTHUR  Z.  EISEN 
T^nLE  V 
Effect of Cell Passage on the Expression of lmmunoreactive Collagenase 
Culture  Passage  Immunoreactive collagenase* 
%C 
WUE 7506  8  376.4 
11  198.6 
12  416.1 
13  322.1 
WUE 7565  5  213.5 
9  228.6 
WUE 76108  4  250.2 
6  949.6 
7  220.4 
10  975.5 
* iHSC content of the cultures was determined as ng/mg protein and expressed 
as the percent of control, 
1383 
experiments, while ~-glucuronidase and lactate dehydrogenase activities were essen- 
tially the same as those of control cultures. A second RDEB line, WUE 7506, displayed 
up to a threefold increase in collagenase activity in these particular experiments while 
having at greatest a  1.8-fold increase in fl-glucuronidase. Lactate dehydrogenase was 
equal  to  that  of the  control  cultures.  These  findings  illustrate  that  in  any  given 
experiment marked increases in collagenase activity can be observed, again suggesting 
that the differences in enzyme activity between experiments are related to variable 
loss of activity in structurally altered enzymes (5). 
As a further measure of the relative capacity of these RDEB fibroblast cultures to 
produce collagenase when compared to normal control lines, total protein synthesis 
was quantitated. Although there was a  2.9-fold increase in collagenase in line WUE 
7506, total protein synthesis was equal to that found in control cultures (202,041 cpm/ 
mg cell protein; 91.5% of control). The other RDEB line, WUE  7572, had approxi- 
mately  two  times  greater  total  protein  synthesis,  (506,361  cpm/mg  cell  protein; 
229.3%  of control), but  this  increase did not  account  for the  greater than  fivefold 
increase in collagenase seen in the experiment. In addition, mean population doubling 
times were determined in control and RDEB fibroblast cultures and found to be 2.20 
+  0.57 days (mean  +  SE) for the control cultures and  1.82  +  0.16 and 2.63  ±  0.51 
days  for WUE  7572  and  WUE  7506,  respectively (P  ffi  NS).  Thus,  the increased 
concentration of iHSC in the RDEB fibroblast cultures was not due to differences in 
the kinetics of growth of the mutant cells. 
If increased production of iHSC  were a  genetic characteristic of RDEB  cells, it 
might be expected that this trait would be expressed throughout several cell passages. 
Three lines were examined in both low and high serial passages (Table V). Although 
each line reflected the intrinsic variability seen between experiments, there was no 
apparent loss of the ability to synthesize increased amounts of iHSC. 
Discussion 
The present study indicates that cell cultures of RDEB patients express an increase 
in immunoreactive collagenase protein analogous to that seen in vivo. It appears that 
this parameter may serve as a genetic marker for at least some of the RDEB patients, 
since 8 out of 10 cell lines studied had significant elevations in iHSC  (Table II). In 1384  RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA 
TABLE VI 
Comparison of in  Vivo and in Vitro lmraunoreactive Collagenase in EB 
Patients 
Patient  In vivo iHSC*  In vitro iHSC$ 
%C  %C 
RDEB 
WUE 76114  383.9  424.1 
WUE 7572  300.4  668.6 
REBL 
WUE 7510  169.2  100.0 
WUE 7514  292.8  70.1 
* Determined as ng/mg tissue dry weight (4). 
:~ Determined as ng/mg protein and expressed as the mean percent of control 
for all experiments performed with each cell line. 
addition, in five of the eight cell lines examined enzyme activity as well as iHSC was 
increased. 
It is important to emphasize that increased collagenase was not seen uniformly in 
fibroblast culture, a finding that suggests that all patients who phenotypically appear 
to have RDEB may not have the same biochemical defect. Since all of the patients in 
this study classified as RDEB were sporadic cases within a  kindred, the two patients 
with normal in vitro production of immunoreactive collagenase might represent new 
mutants for dominant dystrophic EB, although this possibility may prove unlikely on 
clinical grounds (4,  19, 20). 
It is of interest that 4 of the 27 patients whose cells were examined in this study also 
had  previous  in  vivo determinations  of iHSC  (4).  The in  vivo and  in  vitro iHSC 
levels of these patients have been summarized in Table VI, showing that the elevated 
tissue levels of coUagenase in  the RDEB patients are reflected in  vitro.  Despite the 
increased  in  vivo iHSC  in  certain  patients  with  recessive EB  letalis,  a  genetically 
different  form  of EB,  in  vitro  collagenase  was  not  increased.  The  reason  for  the 
increased tissue levels ofcollagenase protein is not known, but it is possible the in vivo 
elevation is reflective of a  chronic wound  healing process in  these severely affected 
recessive EB letalis patients which is not expressed in fibroblast cultures. 
The underlying mechanism for the increased in vitro concentrations of collagenase 
in RDEB fibroblasts is at present unknown. The highest concentrations of iHSC were 
seen most consistently in late log phase growth, a time during which the concentrations 
of many  enzymes  are  most  reflective  of synthesis  and  protein  degradation  is,  in 
general,  lowest  (21).  Until  detailed  studies  of the  biosynthesis  and  degradation  of 
collagenase  in  cell  cultures  are  available,  however,  both  overproduction  and/or 
decreased  degradation  of enzyme protein  represent  possible mechanisms  for iHSC 
accumulation. 
The increased concentration of collagenase appears to be a  specific manifestation 
of the mutant RDEB cells. When a comparison was made between the ability of these 
cells to express collagenase, measured as enzyme activity or immunoreactive material, 
and their ability to express prototypic lysosomal (fl-glucuronidase)  and cytoplasmic 
(lactate  dehydrogenase)  enzymes, collagenase was significantly greater  (Table  IV). 
Furthermore,  neither  a  change  in  mean  population  doubling  times  nor in  general 
protein synthesis appeared to be of sufficient magnitude  to account  for the greater 
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Our  previous studies utilizing cells  from two RDEB  patients  (WU  7506,  WUE 
7565) indicated the collagenases were structurally altered as manifested by decreased 
thermal stability, diminished affinity for Ca  2. and decreased activity per immuno- 
reactive  protein  (5). Despite  the  increased  in  vivo and  in  vitro  concentrations of 
enzyme protein, the finding of functionally altered enzymes raises the question of the 
relationship of the enzyme abnormalities to the disease. As shown in Table III, six 
more patients, in addition to those previously reported (WUE 7506 and WUE 7565), 
have been identified in whose cells collagenase activity per immunoreactive material 
is decreased. The collagenase from one of the additional patients (WUE 76108)  also 
manifests diminished thermal stability and  altered  cofactor and  substrate  kinetics 
(unpublished observations), establishing that this enzyme is structurally altered like 
those of the two previous patients (5). Although the collagenases from the remaining 
patients have not yet been purified and examined for thermal stability and cofactor 
requirements,  if the  apparent  lower  catalytic efficiency (activity/immunoreactive 
protein)  is the result of a structurally altered enzyme, this parameter in conjunction 
with increased accumulation of immunoreactive material would represent an impor- 
tant genetic marker for RDEB. Indeed, the data indicate that in at least three patients 
with RDEB there is overproduction of a structurally defective collagenase. In a similar 
fashion,  overproduction  of  altered  enzymes  has  been  observed  in  other  genetic 
disorders (22-24). 
Although structurally aberrant collagenases occur in vitro, it is clear that if some 
collagenases are functionally near normal in vivo, as suggested by the enzyme activities 
(Table III), overproduction may well have important pathogenetic links to connective 
tissue destruction and blistering. In addition, it is possible that such an increase in 
collagenase may in part explain the decreased or absent anchoring fibrils observed in 
vivo (25, 26). 
Kanan et al.  (27) using electron microscopy have recently reported that cultured 
fibroblasts from RDEB patients contain an increased number of lysosomal bodies 
akin  to  those  seen  in  mucopolysaccharide storage  diseases.  They postulated  that 
alterations in lysosomal function might explain the abnormal collagen metaoblism 
seen in RDEB. Except for the collagenase from polymorphonuclear leukocytes (28, 
29),  there is no evidence to suggest that human collagenases are lysosomal enzymes. 
Indeed, a nonparallel relationship was seen between collagenase and/~-glucuronidase 
in the RDEB lines examined. Thus, the relationship between increased iHSC and the 
increased lysosomal bodies seen on electron microscopy remains to be determined. 
Summary 
Fibroblast  cultures from patients with recessive dystrophic epidermolysis bullosa 
(RDEB)  demonstrated an increased capacity to synthesize and secrete collagenase. 
This phenotypic trait appeared to distinguish RDEB from other genetically distinct 
forms of epidermolysis bullosa. The finding of increased collagenase may be a specific 
manifestation of these cells in that  prototypic lysosomal and cytoplasmic enzymes 
were present in approximately normal concentrations. In addition, this trait persisted 
through many cell passages, suggesting that the property was genetically determined. 
The elevated concentrations of immunoreactive collagenase in fibroblast cultures of 
patients with RDEB reflected those previously observed in vivo (4)  and support the 
concept of a pathogenetic role for the enzyme in the blistering phenomenon. In three 
of the  cell  lines,  the  increase  in  enzyme protein  occurred  in  association  with  a 1386  RECESSIVE  DYSTROPHIC EPIDERMOLYSIS  BULLOSA 
structurally  defective enzyme. The data suggest that  this  may be a  characteristic  of 
all RDEB cells. 
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and the statistical assistance of Dr. Barbara Hixon of the Division of Biostatistics. 
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